Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients

Annals of Surgery

Volumn 248, Issue 3, 2008, Pages 447-456

  Holcomb, John B ^a,h   Wade, Charles E ^a   Michalek, Joel E ^b   Chisholm, Gary B ^b   Zarzabal, Lee Ann ^b   Schreiber, Martin A ^c   Gonzalez, Ernest A ^d   Pomper, Gregory J ^e   Perkins, Jeremy G ^f   Spinella, Phillip C ^g   Williams, Kari L ^a   Park, Myung S ^a  

^a U S ARMY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

^g Divisions of Infectious Diseases Immunology and Excellence in Patient Safety and Clinical Quality   (United States)

^h US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARMY; ARTICLE; ARTIFICIAL VENTILATION; BATTLE INJURY; BLEEDING; BLOOD COMPONENT; DISEASE SEVERITY; EMERGENCY HEALTH SERVICE; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITALIZATION; HUMAN; INJURY SEVERITY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; MULTIPLE TRAUMA; OUTCOME ASSESSMENT; PLASMA TRANSFUSION; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; BLOOD COMPONENT THERAPY; CLINICAL TRIAL; INJURY; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PLASMA; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; BLOOD COMPONENT TRANSFUSION; ERYTHROCYTE TRANSFUSION; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLASMA; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRAUMA CENTERS; WOUNDS AND INJURIES;

EID: 52449086212     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318185a9ad     Document Type: Article

References (106)

1. Holcomb JB, Caruso J, McMullin NR, et al. Causes of death in Special Operations Forces on the modern battlefield: 2001-2006. Ann Surg. 2007;245:986-991.
2. Kelly JF, Ritenour AE, McLaughlin DF, et al. Injury severity and cause of death from Operation Iraqi Freedom and Operation Enduring Freedom: 2003-2204 versus 2006. J Trauma. 2008;64:S21-S27.
3. Teixeira PG, Inaba K, Hadjizacharia P, et al. Preventable or potentially preventable mortality at a mature trauma center. J Trauma. 2007;63:1338 -1347.
4. Tien HC, Spencer F, Tremblay LN, et al. Preventable deaths from hemorrhage at a level I Canadian trauma center. J Trauma. 2007;62:142-146.
5. Gruen RL, Jurkovich GJ, McIntyre LK, et al. Patterns of errors contributing to trauma mortality: lessons learned from 2,594 deaths. Ann Surg. 2006;244:371-380.
6. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38:185-193.
7. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006;60:S3-S11.
8. Heckbert SR, Vedder NB, Hoffman W, et al. Outcome after hemorrhagic shock in trauma patients. J Trauma. 1998;45:545-549.
9. Clarke JR, Trooskin SZ, Doshi PJ, et al. Time to laparotomy for intra-abdominal bleeding from trauma does affect survival for delays up to 90 minutes. JTrauma. 2002;52:420-425.
10. Moore FA, Nelson T, McKinley BA, et al; StO2 Study Group. Massive transfusion in trauma patients: tissue hemoglobin oxygen saturation predicts poor outcome. JTrauma. 2008;64:1010-1023.
11. Yucel N, Lefering R, Maegele M, et al. Trauma associated severe hemorrhage (TASH)-score: probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma. J Trauma. 2006;60:1228-1236; discussion 1236-1227.
12. Schreiber MA, Perkins J, Kiraly L, et al. Early predictors of massive transfusion in combat casualties. J Am Coll Surg. 2007;205:541-545.
13. Cancio LC, Wade CE, West SA, et al. Prediction of mortality and ofthe need for massive transfusion in casualties arriving at combat support hospitals in Iraq. JTrauma. 2008;64:S51-S56.
14. McLaughlin DF, Niles SE, Salinas J, et al. A predictive model for massive transfusion in combat casualty patients. J Trauma. 2008;64:S57-S63.
15. Advanced Trauma Life Support for Doctors. (2nd ed). Chicago, IL: American College of Surgeons; 1997.
16. McMullin NR, Holcomb JB, Sondeen JL. Hemostatic resuscitation. In: Vincent J, ed. Yearbook ofIntensive Care and Emergency Medicine. New York: Springer;2006:265-278.
17. Hess JR, Holcomb JB, Hoyt DB. Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma. Transfusion. 2006;46:685-686.
18. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. JTrauma. 2007; 62:307-310.
19. Cosgriff N, Moore EE, Sauaia A, et al. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma. 1997;42:857-862.
20. Ledgerwood AM, Lucas CE. A review of studies on the effects of hemorrhagic shock and resuscitation on the coagulation profile. J Trauma. 2003;54:S68-S74.
21. Brohi K, Singh J, Heron M, et al. Acute traumatic coagulopathy. J Trauma. 2003;54:1127-1130.
22. MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. J sTrauma. 2003;55:39-44.
23. Borgman M, Spinella PC, Perkins JG, et al. Blood product replacement affects survival in patients receiving massive transfusions at a combat support hospital. JTrauma. 2007;63:805-813.
24. Balogh Z, McKinley BA, Cocanour CS, et al. Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome. Arch Surg. 2003;138:637-643.
25. Alam HB, Rhee P. New developments in fluid resuscitation. Surg Clin North Am. 2007;87:55-72.
26. Cotton BA, Guy JS, Morris JA Jr, et al. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock. 2006;26:115-121.
27. Kiraly LN, Differding JA, Enomoto TM, et al. Resuscitation with normal saline (NS) vs. lactated ringers (LR) modulates hypercoagulability and leads to increased blood loss in an uncontrolled hemorrhagic shock swine model. J Trauma. 2006;61:57-65.
28. Deb S, Sun L, Martin B, et al. Lactated ringer's solution and hetastarch but not plasma resuscitation after rat hemorrhagic shock is associated with immediate lung apoptosis by the up-regulation of the Bax protein. J Trauma. 2000;49:47-55.
29. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564-2575.
30. Como JJ, Dutton RP, Scalea TM, et al. Blood transfusion rates in the care of acute trauma. Transfusion. 2004;44:809-813.
31. Dutton RP, Lefering R, Lynn M. Database predictors oftransfusion and mortality. J Trauma. 2006 Jun;60(suppl 6):S70-S77.
32. Gonzalez EA, Moore FA, Holcomb JB, et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma. 2007;62:112-119.
33. Kashuk J, Moore E, Johnson J, et al. Post-injury life threatening coagulopathy: Is 1:1 fresh frozen plasma (ff): packed red blood red cells rbc the answer? [abstract]. J Trauma. 2007;63:470.
34. Cotton B, Gunter O, Isbell J, et al. Damage control hematology: the impact of trauma exsanguination protocol on survival and blood product utilization. [abstract]. JTrauma. 2007;63:480.
35. Gunter OL, Au BK, Mowery NT, et al. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. [abstract]. J Trauma. 2007;63:1432.
36. Duchesne JC, Hutn JP, Wahl G, et al. Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 ears? [abstract]. JTrauma. 2007;63:481.
37. Sperry J, Ochoa J, Gunn S, et al. A FFP: PRBC transfusion ratio 1:1. 5 is associated with a lower risk of mortality following massive transfusion. [abstract]. J Trauma. 2008;64:247.
38. Gonzalez EA, Jastrow K, Holcomb JB, et al. Early achievement of a 1:1 Ratio of FFP:RBC reduces mortality in patients receiving massive transfusion. [abstract]. J Trauma. 2008;64:247.
39. Scalea T, Bochicchio G, Lumpkins K, et al. Early aggressive use of fresh frozen plasma (FFP) does not improve outcome in critically injured trauma patients. [abstract]. Presention, American Surgical Association. New York, NY.
40. Cinat ME, Wallace WC, Nastanski F, et al. Improved survival following massive transfusion in patients who have undergone trauma. Arch Surg. 1999;134:964-970.
41. Wilson RF, Bassett JS, Walt AJ. Five years of experience with massive blood transfusions. JAMA. 1965 22;194:851-854.
42. Churchill ED. Surgeon to Soldiers. Diary and Records of the Surgical Consultant, Allied Force Headquarters, WWII. JP. Philadelphia, PA: Lippincott Co.; 1972.
43. Carrico CJ, Canizaro PC, Shires GT. Fluid resuscitation following injury: rationale for the use of balanced salt solutions. Crit Care Med. 1976;4:46-54.
44. Shoemaker WC, Appel PL, Kram HB, et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest. 1988;94:1176-1186.
45. Bishop MH, Shoemaker WC, Appel PL, et al. Prospective, randomized trial of survivor values of cardiac index, oxygen delivery, and oxygen consumption as resuscitation endpoints in severe trauma. J Trauma. 1995;38:780-787.
46. Martin DJ, Lucas CE, Ledgerwood AM, et al. Fresh frozen plasma supplement to massive red blood cell transfusion. Ann Surg. 1985;202: 505-511.
47. Harrigan C, Lucas CE, Ledgerwood AM, et al. Serial changes in primary hemostasis after massive transfusion. Surgery. 1985;98:836-844.
48. Lucas CE, Ledgerwood AM, Saxe JM. Plasma supplementation is beneficial for coagulation during severe hemorrhagic shock. Am J Surg. 1996;171:399-404.
49. Shapiro MB, Jenkins DH, Schwab CW, et al. Damage control: collective review. JTrauma. 2000;49:969 -978.
50. Rotondo MF, Schwab CW, McGonigal MD, et al. "Damage control:" an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma. 1993;35:375-383.
51. Rotondo MF, Zonies DH. The damage control sequence and underlying logic. Surg Clin North Am. 1997;77:761-777.
52. Morris JA Jr, Eddy VA, Blinman TA, et al. The staged celiotomy for trauma. Issues in unpacking and reconstruction. Ann Surg. 1993;217:576-586.
53. Kirkpatrick AW, Balogh Z, Ball CG, et al. The secondary abdominal compartment syndrome: iatrogenic or unavoidable? J Am Coll Surg. 2006;202:668-679.
54. Madigan MC, Kemp CD, Johnson JC, et al. Secondary abdominal compartment syndrome after severe extremity injury: are early, aggressive fluid resuscitation strategies to blame? JTrauma. 2008;64:280-285.
55. Plurad D, Martin M, Green D, et al. The decreasing incidence of late posttraumatic acute respiratory distress syndrome: the potential role of lung protective ventilation and conservative transfusion practice. J Trauma. 2007;63:1-8.
56. Hirshberg A, Dugas M, Banez EI, et al. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma. 2003;54:454-463.
57. Ho AM, Karmakar MK, Dion PW. Are we giving enough coagulation factors during major trauma resuscitation? Am J Surg. 2005;190:479-484.
58. Moore FD, Shires GT. Moderation. Anesth Analg. 1968;47:506-508.
59. Moore FA, McKinley BA, Moore EE. The next generation in shock resuscitation. Lancet. 2004;363:1988-1996.
60. Hoyt DB. Fluid resuscitation: the target from an analysis of trauma systems and patient survival. JTrauma. 2003;54:S31-S35.
61. Holcomb JB. Fluid resuscitation in modern combat casualty care: lessons learned from Somalia. JTrauma. 2003;54:S46 -S51.
62. Wade CE, Holcomb JB. Endpoints in clinical trials of fluid resuscitation of patients with traumatic injuries. Transfusion. 2005;45:4S-8S.
63. Bickell WH, Wall MJ Jr, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. NEnglJMed. 1994;331:1105-1109.
64. Bagshaw SM, Bellomo R. The influence of volume management on outcome. Curr Opin Crit Care. 2007;13:541-548.
65. Fox CJ, Gillespie DL, Cox ED, et al. The effectiveness of a damage control resuscitation strategy for vascular injury in a combat support hospital: results ofa case control study. JTrauma. 2008;64:S99-S107.
66. Spinella PC, Perkins JG, Grathwohl KW, et al. Effect ofplasma and red blood cell transfusions on survival in patients with combat related traumatic injuries. JTrauma. 2008;64:S69 -S78.
67. Spinella PC, Perkins JG, Grathwohl KW, et al; 31st Combat Support Hospital Research Working Group. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital. Crit Care Med. 2007;35:2576-2581.
68. Repine TB, Perkins JG, Kauvar DS, et al. The use offresh whole blood in massive transfusion. JTrauma. 2006;60:S59-S69.
69. Kauvar DS, Holcomb JB, Norris GC, et al. Fresh whole blood transfusion: a controversial military practice. JTrauma. 2006;61:181-184.
70. Moore FA, Nelson T, McKinley BA, et al. and the StO2 Study Group. Is there a role for aggressive use of fresh frozen plasma in massive transfusion of civilian trauma patients? Am J Surg. 2008. [in press].
71. Johansson PI, Stensballe J, Rosenberg I, et al. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. Transfusion. 2007;47:593-598.
72. Ketchum L, Hess JR, Hiippala S. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma. 2006;60:S51-S58.
73. Malone DL, Hess JR, Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma. 2006;60:S91-S96.
74. Hess JR, Hiippala S. Optimizing the use of blood products in trauma care. Crit Care. 2005;9:S10 -S14.
75. Armand R, Hess JR. Treating coagulopathy in trauma patients. Transfus Med Rev. 2003;17:223-231.
76. Hess JR, Zimrin AB. Massive blood transfusion for trauma. Curr Opin Hematol. 2005;12:488 -492.
77. Hellstern P, Haubelt H. Indications for plasma in massive transfusion. Thromb Res. 2002;107:S19-S22.
78. Brohi K, Cohen MJ, Ganter MT, et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through protein C pathway? Ann Surg. 2007;245:812-818.
79. Ganter MT, Cohen MJ, Brohi K, et al. Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma? Ann Surg. 2008;247:320-326.
80. Hess JR. Blood and coagulation support in trauma care. Hematology Am Soc Hematol Educ Program. 2007;2007:187-191.
81. Fries D, InnerhoferP, Reif C, et al. The effect of fibrinogen substitution on reversal ofdilutional coagulopathy: an in vitro model. Anesth Analg. 2006;102:347-351.
82. Stinger HK, Spinella PC, Perkins JP, et al. The ratio of fibrinogen to red cells transfused improves survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma. 2008;64: S79-S85.
83. Martini WZ, Chinkes DL, Pusateri AE, et al. Acute changes in fibrinogen metabolism and coagulation after hemorrhage in pigs. Am J Physiol Endocrinol Metab. 2005;289:E930-E934.
84. Traverso LW, Hollenbach SJ, Bolin RB, et al. Fluid resuscitation after an otherwise fatal hemorrhage: II. Colloid solutions. JTrauma. 1986; 26:176-182.
85. Johansson PI. The blood bank: from provider to partner in treatment of massively bleeding patients. Transfusion. 2007;47:176S-183S.
86. Johansson PI, Hansen MB, Sørensen H. Transfusion practice in massively bleeding patients: time for a change? Vox Sang. 2005;89:92-96.
87. Geeraedts LM Jr, Demiral H, Schaap NP, et al. 'Blind' transfusion of blood products in exsanguinating trauma patients. Resuscitation. 2007;73:382-388.
88. Simmons RL, Collins JA, Heisterkamp CA, et al. Coagulation disorders in combat casualties. I. Acute changes after wounding. II. Effects of massive transfusion. 3. Post-resuscitative changes. Ann Surg. 1969;169:455-482.
89. Miller RD, Robbins TO, Tong MJ, et al. Coagulation defects associated with massive blood transfusions. Ann Surg. 1971;174:794-801.
90. McNamara JJ, Burran EL, Stremple JF, et al. Coagulopathy after major combat injury: occurrence, management, and pathophysiology. Ann Surg. 1972;176:243-246.
91. Marumo M, Suehiro A, Kakishita E, et al. Extracellular pH affects platelet aggregation associated with modulation of store-operated Ca (2+) entry. Thromb Res. 2001;104:353-360.
92. Valeri CR, Feingold H, Cassidy G, et al. Hypothermia-induced reversible platelet dysfunction. Ann Surg. 1987;205:175-181.
93. Counts RB, Haisch C, Simon TL, et al. Hemostasis in massively transfused trauma patients. Ann Surg. 1979;190:91-99.
94. Contreras M. Consensus conference on platelet transfusion: final statement. Vox Sang. 1998;75:173-174.
95. Stainsby D, MacLennan S, Thomas D, et al. Guidelines on the management of massive blood loss. Br JHaematol. 2006;135:634-641.
96. Reed RL II, Ciavarella D, Heimbach DM, et al. Prophylactic platelet administration during massive transfusion. A prospective, randomized, double-blind clinical study. Ann Surg. 1986;203:40-48.
97. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol. 2003;122:10-23.
98. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, et al. ; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br JHaematol. 2004;126:11-28.
99. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on perioperative blood transfusion and adjuvant therapies. Anesthesiology. 2006;105:198-208.
100. Stanworth SJ. The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology Am Soc Hematol Educ Program. 2007;2007:179-186.
101. MacLennan S, Williamson LM. Risks of fresh frozen plasma and platelets. JTrauma. 2006;60:S46-S50.
102. Norda R, Tynell E, Akerblom O. Cumulative risks of early fresh frozen plasma, cryoprecipitate and platelet transfusion in Europe. J Trauma. 2006;60:S41-S45.
103. Flesland O. A comparison of complication rates based on published haemovigilance data. Intensive Care Med. 2007;33:S17-S21.
104. Bux J. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang. 2005;89:1-10.
105. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol. 2007;136:788-799.
106. Resources for the Optimal Care ofthe Injured Patient. American College of Surgeons Committee on Trauma, American College of Surgeons. Chicago, Illinois. 2006;67.